"Never doubt that a small group of thoughtful, committed citizens can change the world. Indeed, it is the only thing that ever has."

Margaret Mead
TO ARTICLE
METRICS

Case report
peer-reviewed

COVID-19 Induced Hepatitis B Virus Reactivation: A Novel Case From the United Arab Emirates


Total Article Reads

Article reads consist of online article views and PDF downloads. Cureus data is delayed by 24 hours and PMC data is delayed by approximately one month.

Total Article Reads Cureus PMC
11,670 Article Views 1,920 8,643
PDF Downloads 521 586
Total Article Reads Cureus PMC
11,670 Article Views 1,920 8,643
PDF Downloads 521 586
Total Article Reads
11,670
Cureus PMC
Article Views 1,920 8,643
PDF Downloads 521 586

Article Reads by Date

Hover your cursor over a specific day or month to see the corresponding online article views and PDF downloads. Cureus data is delayed by 24 hours and PMC data is delayed by approximately one month.

Cureus Article Reads

Loading...

Cumulative Cureus and PMC Article Reads

Loading...

Article Reads by Country

Hover your cursor over a country to see the number of online article views and PDF downloads from Cureus only.
Note: PMC does not share location data and not all Cureus reads are included below as location data is not available for all IP addresses.


Rank Country Views Percentage

Article Reads by U.S. States

Hover your cursor over a state to see the number of online article views and PDF downloads from Cureus only.
Note: PMC does not share location data and not all Cureus reads are included below as location data is not available for all IP addresses.


Rank State Views Percentage

Citations

Citation index reporting varies. Crossref citations are listed below and Google Scholar citations can be seen by clicking the corresponding button.

Google Scholar  
Crossref Citations (17)
  1. Saeed, U., Piracha, Z. Z., Uppal, S. R., Waheed, Y., & Uppal, R. (2022). SARS-CoV-2 induced hepatic injuries and liver complications. Frontiers in Cellular and Infection Microbiology, 12. https://doi.org/10.3389/fcimb.2022.726263 doi:10.3389/fcimb.2022.726263.
  2. Villar, L. M., de Paula, V. S., Pinto, L. C. M., Marques, B. C. L., da Costa, V. D., da Silva, L. L., Santos, A. C., do Nascimento, G. P., Miguel, J. C., Mendonça, A. C. da F., Motta, F. C., & Lewis‐Ximenez, L. L. (2021). Clinical and laboratory characteristics of hepatitis C and COVID‐19 coinfection: Prolonged RNA shedding in nonhospitalized case. Clinical Case Reports, 9(8). Portico. https://doi.org/10.1002/ccr3.3877 doi:10.1002/ccr3.3877.
  3. Sagnelli, C., Montella, L., Grimaldi, P., Pisaturo, M., Alessio, L., De Pascalis, S., Sagnelli, E., & Coppola, N. (2022). COVID-19 as Another Trigger for HBV Reactivation: Clinical Case and Review of Literature. Pathogens, 11(7), 816. https://doi.org/10.3390/pathogens11070816 doi:10.3390/pathogens11070816.
  4. Wallington, S. F., Jeon, M. J., Nguyen, T. A., Byambaa, C., Yang, Y. T., & Le, D. (2022). Perceptions and patient care needs among hepatitis B patients during COVID-19. BMC Health Services Research, 22(1). https://doi.org/10.1186/s12913-022-08153-5 doi:10.1186/s12913-022-08153-5.
  5. Hu, C. Y., Tsou, Y.-F., Chung, M.-H., Lin, N.-C., Chen, C.-Y., Lee, P.-C., & Liu, C.-S. (2022). Hepatitis B Virus Infection Flare Induced Acute-on-chronic Liver Failure After COVID-19 Vaccination: A Case Report. Hepatitis Monthly, 21(12). https://doi.org/10.5812/hepatmon-126460 doi:10.5812/hepatmon-126460.
  6. Baroiu, L., Anghel, L., Tatu, A., Iancu, A., Dumitru, C., Leșe, A.-C., Drăgănescu, M., Năstase, F., Niculeț, E., Fotea, S., Nechita, A., Voinescu, D., & Stefanopol, A. (2022). Risk of hepatitis B reactivation: From biologic therapies for psoriasis to immunosuppressive therapies for COVID‑19 (Review). Experimental and Therapeutic Medicine, 23(6). https://doi.org/10.3892/etm.2022.11312 doi:10.3892/etm.2022.11312.
  7. Sagnelli, C., Sica, A., Creta, M., Borsetti, A., Ciccozzi, M., & Sagnelli, E. (2022). Prevention of HBV Reactivation in Hemato-Oncologic Setting during COVID-19. Pathogens, 11(5), 567. https://doi.org/10.3390/pathogens11050567 doi:10.3390/pathogens11050567.
  8. Mastroianni, A., Greco, S., Chidichimo, L., Mauro, M. V., Urso, F., & Vangeli, V. (2022). Antiviral prophylaxis for hepatitis B virus in COVID-19 patients treated with immunosuppressive drug therapy. Antiviral Therapy, 27(1), 135965352110676. https://doi.org/10.1177/13596535211067602 doi:10.1177/13596535211067602.
  9. Cao, X., Wang, Y., Li, P., Huang, W., Lu, X., & Lu, H. (2021). HBV Reactivation During the Treatment of Non-Hodgkin Lymphoma and Management Strategies. Frontiers in Oncology, 11. https://doi.org/10.3389/fonc.2021.685706 doi:10.3389/fonc.2021.685706.
  10. SeyedAlinaghi, S., Oliaei, S., Kianzad, S., Afsahi, A. M., MohsseniPour, M., Barzegary, A., Mirzapour, P., Behnezhad, F., Noori, T., Mehraeen, E., Dadras, O., Voltarelli, F., & Sabatier, J.-M. (2020). Reinfection risk of novel coronavirus (CoVID-19): A systematic ‎review of current evidence. World Journal of Virology, 9(5), 79–90. https://doi.org/10.5501/wjv.v9.i5.79 doi:10.5501/wjv.v9.i5.79.
  11. Krenytska, D., Rachkovska, A., Savchuk, O., … Karbovskiy, V. (2021). Biochemical parameters of the functional state liver in patients with hepatitis Under conditions of SARS-CoV-2 coinfection. Bulletin of Taras Shevchenko National University of Kyiv. Series: Biology, (87), 12–17. doi:10.17721/1728.2748.2021.87.12-17.
  12. Rostami, T., Alijani, N., Kiumarsi, A., Rad, S., Mirhoseini, S. A., … Rostami, M. (2021). Tocilizumab in Post Hematopoietic Stem Cell Transplant COVID-19: A Pediatric Case Report. Journal of Medical Microbiology and Infectious Diseases, 9(4), 225–229. doi:10.52547/JoMMID.9.4.225.
  13. Gyandev Gondode, P., Garg, A., Sahoo, S., … Sharma, A. (2021). The quandary over Antiviral Therapy for a COVID-19 Patient with Glucose-6-Phosphate Dehydrogenase Deficiency, Hypertension, and Resolved Hepatitis B Infection: A Case Report. Journal of Medical Microbiology and Infectious Diseases, 9(4), 221–224. doi:10.52547/JoMMID.9.4.221.
  14. Ali, F. E. M., Mohammedsaleh, Z. M., Ali, M. M., & Ghogar, O. M. (2021). Impact of cytokine storm and systemic inflammation on liver impairment patients infected by SARS-CoV-2: Prospective therapeutic challenges. World Journal of Gastroenterology, 27(15), 1531–1552. doi:10.3748/wjg.v27.i15.1531.
  15. Han, M.-W., Wang, M., Xu, M.-Y., Qi, W.-P., Wang, P., & Xi, D. (2021). Clinical features and potential mechanism of coronavirus disease 2019-associated liver injury. World Journal of Clinical Cases, 9(3), 528–539. doi:10.12998/wjcc.v9.i3.528.
  16. Mirzaie, H., Vahidi, M., Shokoohi, M., Darvishian, M., Sharifi, H., Sharafi, H., & Karamouzian, M. (2021). Coronavirus Disease 2019 (COVID-19) Among Patients With Hepatitis B or Hepatitis C: A Systematic Review. Hepatitis Monthly, In Press(In Press). doi:10.5812/hepatmon.111617.
  17. Niankara, I., Muqattash, R., Niankara, A., & Traoret, R. I. (2020). COVID-19 Vaccine Development in a Quadruple Helix Innovation System: Uncovering the Preferences of the Fourth Helix in the UAE. Journal of Open Innovation: Technology, Market, and Complexity, 6(4), 132. doi:10.3390/joitmc6040132.

Article Research Metrics

We’ve partnered with Plum Analytics to track and display research metrics for each article. (All data provided by PlumX Metrics.) Click here to learn more about Plum Analytics.